SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001600132-20-000027
Filing Date
2020-03-30
Accepted
2020-03-30 16:09:04
Documents
6
Period of Report
2020-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kmarch2020rd.htm 8-K 36674
2 EXHIBIT 1.1 a8-kmar2020offeringex11.htm EX-1.1 53694
3 EXHIBIT 5.1 a8-kmar2020offeringex51.htm EX-5.1 12679
4 EXHIBIT 10.1 a8-kmar2020offeringex101.htm EX-10.1 196546
5 EXHIBIT 99.1 a8-kmar2020offeringex991.htm EX-99.1 11570
6 mintz.jpg GRAPHIC 3698
  Complete submission text file 0001600132-20-000027.txt   317590
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Filer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36845 | Film No.: 20757065
SIC: 2834 Pharmaceutical Preparations